{"slug":"verona-pharma","name":"Verona Pharma","url":"https://www.gp-intel.com/company/verona-pharma","sector":"Biotech","country":"United Kingdom","hq_city":null,"website":"https://www.veronapharma.com","founded_year":null,"ipo_year":null,"status":"exited","current_owner":null,"current_holder":{"name":"Merck","names":["Merck"],"since_year":2025,"basis":"trade_sale"},"ownership_periods":3,"ownership":[{"owner":"Andera Partners","fund":"BioDiscovery 4","fund_vintage":2013,"entry_year":2016,"exit_year":2017,"is_exit":true,"deal_type":"Trade Sale","buyer":null,"moic":null,"sector":"Biotech"},{"owner":"Sofinnova Partners","fund":"Sofinnova Crossover Fund I","fund_vintage":2018,"entry_year":2019,"exit_year":2025,"is_exit":true,"deal_type":"Trade Sale","buyer":"Merck (MSD)","moic":null,"sector":"Biotech"},{"owner":"Abingworth","fund":"Abingworth Bioventures VI","fund_vintage":2014,"entry_year":null,"exit_year":2025,"is_exit":true,"deal_type":"Trade Sale","buyer":"Merck & Co.","moic":null,"sector":"Biotech"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-04-21T14:45:54.545Z"}